Dinglan Zuo
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis.
Journal: Cancer research
Published: January 20, 2026
COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling.
Journal: Clinical and molecular hepatology
Published: September 26, 2025
USP14-mediated metabolic competition impairs CD8+ T cell immunosurveillance in hepatocellular carcinoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 18, 2025
Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 19, 2024
KLF4 Suppresses the Progression of Hepatocellular Carcinoma by Reducing Tumor ATP Synthesis through Targeting the Mir-206/RICTOR Axis.
Journal: International journal of molecular sciences
Published: May 24, 2024
m6A-mediated lnc-OXAR promotes oxaliplatin resistance by enhancing Ku70 stability in non-alcoholic steatohepatitis-related hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 23, 2024
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling.
Journal: Nature communications
Published: November 17, 2023
Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APCmin+/- mice.
Journal: iScience
Published: September 24, 2023
METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition.
Journal: Cell death discovery
Published: September 07, 2023
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma.
Journal: Cancer cell international
Published: August 09, 2023
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.
Journal: Clinical and translational medicine
Published: March 08, 2023
Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma.
Journal: Journal of clinical and translational hepatology
Published: August 18, 2022
Last Updated: 09/26/2026